SCHEDULE 13D/A: Paulson & Co. Boosts Stake in Bausch Health to 8.9% Through Recent Share Purchases

Paulson & Co. Inc. has significantly increased its beneficial ownership in Bausch Health Companies Inc. to 8.9% through a series of recent common share acquisitions.

Summary

• Paulson & Co. Inc. filed Amendment No. 4 to its Schedule 13D, reporting an updated beneficial ownership in Bausch Health Companies Inc.
• As of the filing date, Paulson & Co. beneficially owns 32,791,702 common shares of Bausch Health.
• This ownership represents approximately 8.9% of the outstanding common shares, based on 367,933,897 shares outstanding as of February 14, 2025.
• Paulson & Co. has sole voting and dispositive power over all 32,791,702 shares.
• The filing details several recent purchases of Bausch Health common stock by Paulson & Co. within the past 60 days, totaling 6,352,667 shares.
• These purchases occurred between June 10, 2025, and June 13, 2025, at prices ranging from $5.05 to $5.94 per share.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a major investment firm significantly increasing its stake, suggesting confidence in the company's valuation or future performance.

Positives

• A significant increase in beneficial ownership by a major investment firm like Paulson & Co. may signal confidence in Bausch Health's future prospects.
• The consistent buying activity over several days indicates a deliberate strategy to accumulate shares at current price levels.

Negatives

• The share purchase prices, ranging from $5.05 to $5.94, suggest that Paulson & Co. was acquiring shares at relatively low valuations, which could imply recent price weakness for Bausch Health's stock.

Future Outlook

This Schedule 13D filing does not contain forward-looking statements or guidance from Bausch Health Companies Inc. It primarily reports changes in beneficial ownership by Paulson & Co. Inc.

Industry Context

The increased stake by Paulson & Co., a prominent activist investor, in Bausch Health Companies Inc. could signal a belief in the company's undervalued assets or potential for strategic changes within the pharmaceutical and healthcare industry. Such moves by large institutional investors often draw attention to the company and its sector, potentially influencing market sentiment.

Stakeholder Impact

• Shareholders: The increased stake by a major investor like Paulson & Co. could be perceived positively, potentially leading to increased investor confidence and upward pressure on the stock price. It may also signal potential for future corporate actions or strategic shifts influenced by a large shareholder.
• Management: Increased ownership by an activist investor could lead to greater scrutiny of management decisions and potentially influence strategic direction or operational efficiency.

Key Dates

Recommendation

Keywords

Bausch Health Companies Inc., Paulson & Co. Inc., Schedule 13D, Beneficial Ownership, Common Shares, Stock Acquisition, Investment Firm, Pharmaceuticals, Healthcare